Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No 50 by end of year. Any predictions for 2015? I am quite negative, YoY and Q1oQ1 will look very bad and may send the stock all the way to 20 or below...
What exactly did CNBC cover?
I bought some NuSkin products today for my wife. I've done my part to increase their revenues :)
we'll see tomorrow. It seemed like when CNBC started talking about it today it went down. It might be up tomorrow.
First half of the day looked very good, but the LOD close is a bit scary...
Reached 45 today. 50 by end of year?
Only those brainwashed by them think that this is a legit business model. Daydreaming of being on the top and being a millionaire. Look up pyramid scheme.
Pyramid scheme type business never meet expected earning by far. This scam of a stock will hit rock bottom hard once authority scrutinize their pyramid scheme
Oh c'mon NUS, investor's conference wasn't all that bad!
http://ir.nuskin.com/phoenix.zhtml?c=103888&p=irol-newsArticle&ID=1999052
NU SKIN ENTERPRISES HOSTS ANNUAL INVESTOR CONFERENCE
Company Announces New Direct Selling Licenses in China
PROVO, Utah, Dec. 12, 2014 /PRNewswire/ -- Nu Skin Enterprises (NYSE:NUS) will host its annual investor conference today at the Nu Skin Innovation Center at its global headquarters in Provo, Utah. The company's management team will share more details of its 2015 and longer-term growth plans at the event.
"We are pleased to be hosting our annual investor event at our new Innovation Center and look forward to discussing growth plans," said Truman Hunt, president and chief executive officer. "We have several exciting product and business initiatives that we believe will help generate growth in our business globally. In 2015, we plan to introduce what we consider to be the most ground-breaking anti-aging products in our corporate history. These new anti-aging innovations will bring technology-based customization to our skin care portfolio, as well as advanced nutritional support for the body."
Nu Skin also announced that it has received official approval to commence direct selling activities in five new districts in Shanghai and two new cities in Jiangsu Province. The licensing process included a review of the company's operations and expands Nu Skin's direct selling footprint in the market.
Nu Skin will discuss 2015 financial guidance at its annual investor day conference. The company projects 2015 revenue of $2.50 to $2.56 billion, representing growth of 4 to 6 percent in local currency. This revenue level reflects a negative foreign currency impact of 6 percent. Earnings per share are estimated to be $3.80 to $4.00.
A webcast of the event will start at noon EST and will be available at http://ir.nuskin.com. A replay of the webcast, along with accompanying slides and financial information, will be made available from the same location through Dec. 31, 2014.
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the new ageLOC® line of products including ageLOC® Tru Face® Essence Ultra firming serum, the ageLOC® TR90® weight management and body shaping system, ageLOC® R2 nutritional supplement, and ageLOC® Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol 'NUS.' More information is available at http://www.nuskin.com.
Please Note: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, sales force, strategies and new product introductions; statements of projections regarding revenue, earnings per share, foreign currency impact and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
risk that continuing media and regulatory scrutiny and investigations in China, and any actions taken by the company or by regulators, could cause unanticipated complications or other difficulties, make it more difficult to forecast results for future periods, and could negatively impact the company's revenue, sales force and business in this market, including the interruption of sales activities, loss of licenses, and the imposition of fines, and any other adverse actions or events;
risks related to negative publicity regarding recent media allegations and subsequent regulatory investigations and fines;
risk that direct selling regulations in China may be modified, interpreted or enforced in a manner that results in negative changes to our business model or the imposition of a range of potential penalties;
any failure of current or planned initiatives or products to generate interest among our sales force and customers and generate sponsoring and selling activities on a sustained basis;
risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, and increased risk of inventory write-offs if we over-forecast demand for a product or change our planned initiatives or launch strategies;
risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;
unpredictable economic conditions and events globally;
regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;
adverse publicity related to the company's business, products, industry or any legal actions or complaints by the company's sales force or others;
any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and
continued competitive pressures in the company's markets.
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained herein to reflect any change except as required by law.
GAAP RECONCILIATION
Projected 2015 Range
Revenue Growth -2.0% to 0.0%
FX Impact -6.0%
Local - Currency Revenue Growth 4.0% to 6.0%
Monday morning and weekly chart looks very solid! Over 20% up from recent low and counting!
Monday morning and weekly chart looks very solid! Over 20% up from recent low and counting!
over $44 and looking strong. Next week is the investor conference. I'm just afraid that even if Q4 numbers will be in line with expectations, it is still too low compared with Q4'13...
So.. Now what?
Was that the bottom? Should we expect it to grow till end of year?
Next Q's guidance was awful. They've been rocking 4th quarters for several years in a row. If they really end up in the ~600 M range, the stock is going to get killed.
Holding tight here. Wish I'd sold but was hopeful for better Q's
Earnings report was bad........
Guidance was really bad, a huge drop. NUS down 23% in premarket. Glad I sold off Monday. Now I kinda wish I bought some puts.
Sold off everything after a 8% gain.
I want to sit out of Wednesdays earnings report. If it is bad, I expect a huge plunge. If it is good I might buy back in afterword's.
At MLMrankings.com the public interest ranking took a huge plunge back in march and has stayed near rock bottom since. I am afraid this will make it tough to hold onto sales. I suspect the earnings report won't look to good.
coming back from the dead!!
On the day before holloween nus popped for a 8% gain. This stock is going to come back from the dead. Andrew Left tried to kill this company. He made millions shorting this company in a shellfish narsistic attack. this is well run fast growing and very profitable company. the company paid fines and is now on it's way to recovery. I bought in and expect huge gains. The same great management team is still here. knocked down from a devastating punch but not knocked out.
Nus is going to come roaring back!!!!
Expect this to pop to 90-100 if not more coming month... but we shall see
in apr 90 and 100 calls
Expect this to pop to 90-100 if not more coming month... but we shall see
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Nu Skin Enterprises
https://invest.ameritrade.com/grid/p/site#r=jPage/https://research.ameritrade.com/grid/wwws/stocks/news/story.asp?docKey=100-083u6814-1&searchCategory=latest&c_name=invest_VENDOR
Looking Bearish. More profit takers for today. Price target $82 end of the day IMO
Cut your losses or short this company. With the whole Chinese probing, it caused many people to stop using their products. Next ER will eat you alive with huge losses. PT $42 END OF YEAR.
Sell sell sell. Entry $82. Wait for it to go down. $90 is unstable and keeps going down.
Would love to see that $81. I bought the $80 PUTS kind of on a whim this morning. I don't see this sustaining, but I could be wrong.
Didn't buy that much, but enough to make a good lotto play :)
Good luck to us!
Shorted at $101.77 today! Entry is at $81 wait it out or short it down
SELL SELL SELL THIS SCAM!
NUS Weekly Chart: checkout that brutal fall from Grace.........every Bears dream play........way to go China, stick it to em!...........think P&D pyramid scheme on steroids........that's NUS According to the Chinese govt.......
http://www.reuters.com/article/2014/01/17/us-china-nuskin-herbalife-idUSBREA0G05A20140117
Looks like HLF is next.........the classic battle between heavy weights Ackman & Icahn has been one for the ages.........Icahn & Soros are HLF bulls & Ackman is betting on the share price going to zero.......now that the Chinese govt. is probing NUS it looks like HLF is on deck.......should see some wild price swings & great long & short trading opportunities as the saga unfolds..........$$$
Nu Skinned Alive lol time for rebound? After the Chinese news/rumors that pummeled NU Skin the last 2 days, the company has finally been forced to make a statement...
*NU SKIN AWARE CHINESE REGS INITIATED INVESTIGATIONS
*NU SKIN SAYS LIKELY NEGATIVE EFFECT ON CHINA REV
*NU SKIN HAS STARTED OWN PROVINCE-BY-PROVINCE BUSINESS REVIEW
After being halted on news pending, NUS was re-halted upon re-opening, plunged further, and is now re-halted down $45 (39%. Herbalife (down 12%) and USANA (down 12%) are also tumbling on this news.
CHARTS:
Bouncing now...
Here's who is hurting the most...
http://www.zerohedge.com/news/2014-01-16/nu-skin-halted-third-time-down-45
That's good just thought I'd let cha know just in case..
Have a good night
covered at premarket. i never short for 2 trading sessions.
Nice trade lol - my orders didn't fill "sigh " it was worth a shot lol
Just like I said, I should have been sitting on puts!
I had some of last friday's puts Blah!
Got out at 1.20 lol
Put a couple stupid low bids in - between $1-$10 lmfao
Won't get filled but I've seen crazier chit happen before lol
Bought 1 weekly call for .60 let's go lol 90 strike
Just a minor pull back on the weekly chart lol
Will it bounce lol
Took 30 sec to trip another breaker lol
Heads up my friend if your still short - halted
my stops trigger at $128 lol got in as a short at 123
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
161
|
Created
|
08/08/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |